Antimicrobial

A researcher at the UF Emerging Pathogens Institute partners with a tech company to study sterilization of samples received from Space.

A UF researcher with expertise in infectious bacteria offers commentary and perspective on extensively drug-resistant Shigella infections following a recent CDC warning.

UF’s EPI is partnering with Gainesville-based tech company SurfPlasma, Inc. to test a new device’s ability to kill pathogens — even the celestial kinds.

Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment time — and cure — a patient with extensively drug-resistant TB.

New work from the lab of Tony Maurelli, associate chair of the department of environmental and global health in UF's College of Public Health and Health Professions, has solved a quirky mystery about parasitic bacteria that cause the sexually-transmitted disease known as Chlamydia.

EPI investigator KC Jeong aims to uncover the next generation of antimicrobials. From his microbiology lab to an experimental farm, his research explores how food animals are affected by novel and drug-resistant pathogens — and what kills them.

An Emerging Pathogens Institute microbiologist has identified high concentrations of naturally-occurring antibiotic-resistant microbes within the guts of grazing cows and calves fed a diet free from antibiotics. The source? Soil, water and forage found in the cows’ environment.

B. pseudomallei possess intrinsic antibiotic resistance, do not always acquire resistance genes from other bacteria via usual route.

A University of Florida scientist will try to figure out how antibiotic-resistant microorganisms get into cattle. Another will study how to get tomatoes and strawberries to retain their flavors and last longer.